NEW PRAGUE, Minn. / Apr 27, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Inaugural EF Hutton Global Conference on May 10-11, 2023 at the Plaza Hotel in New York, New York. Management will be available for one-on-one meetings on Thursday, May 11, 2023.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
| Last Trade: | US$18.93 |
| Daily Change: | -0.24 -1.25 |
| Daily Volume: | 63,476 |
| Market Cap: | US$158.820M |
April 03, 2025 November 12, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
